Want to join the conversation?
$ALXN now expects 2016 research and development expense to be at high end of prior forecast of $650-680MM and selling, general and administrative expense to be at high end of prior $760-790MM outlook. The company still expects interest expense of $100MM, effective tax rate of 7-8% and diluted shares outstanding of 230MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?